Clinitech Laboratory Limited IPO 2024 Details

Clinitech Laboratory’s IPO is a fixed price issue of Rs 5.78 crores, consisting entirely of a fresh issue of 6.02 lakh shares.

The IPO bidding opened for subscription on July 25, 2024, and will close on July 29, 2024. The allotment is expected to be finalized on Tuesday, July 30, 2024, with a tentative listing date on BSE SME set for Thursday, August 1, 2024.

The IPO price is ₹96 per share, with a minimum application lot size of 1200 shares, requiring an investment of ₹115,200 for retail investors. For HNIs, the minimum lot size is 2 lots (2,400 shares), amounting to ₹230,400.

  • Book Running Lead Manager of Clinitech IPO – Inventure Merchant Banker Services Pvt Ltd.
  • Registrar for the issue – Bigshare Services Pvt Ltd.
  • Market Maker for Clinitech Laboratory IPO – Svcm Securities.

Below are the details of Clinitech Laboratory Limited IPO 2024 Details, Timeline, Lot Size, Anchor Investor, and Promoter Holding.

Track All IPOs opening and closing today on our comprehensive list of IPO Watchlist 2024!

Clinitech Laboratory Limited IPO 2024 Details

IPO DateJuly 25, 2024 to July 29, 2024
Listing Date[.]
Face Value₹10 per share
Price₹96 per share
Lot Size1200 Shares
Total Issue Size602,400 shares
(aggregating up to ₹5.78 Cr)
Fresh Issue602,400 shares
(aggregating up to ₹5.78 Cr)
Issue TypeFixed Price Issue IPO
Listing AtBSE SME
Share holding pre issue1,680,000
Share holding post issue2,282,400
Market Maker portion31,200 shares
Svcm Securities

Clinitech Laboratory IPO 2024 Timeline

EventTimeline
IPO Open DateThursday, July 25, 2024
IPO Close DateMonday, July 29, 2024
Basis of AllotmentTuesday, July 30, 2024
Initiation of RefundsWednesday, July 31, 2024
Credit of Shares to DematWednesday, July 31, 2024
Listing DateThursday, August 1, 2024
Cut-off time for UPI mandate confirmation5 PM on July 29, 2024

Clinitech Laboratory IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)11200₹115,200
Retail (Max)11200₹115,200
HNI (Min)22,400₹230,400

Clinitech Laboratory Limited IPO Reservation

Investor CategoryShares Offered
Anchor Investor Shares Offered
Market Maker Shares Offered31,200 (5.18%)
Other Shares Offered301,200 (50.00%)
Retail Shares Offered301,200 (50.00%)
Total Shares Offered602,400 (100%)

Clinitech Laboratory Limited IPO Promoters

Jagdish Umakant Nayak, Jyoti Jagdish Nayak, and Ashutosh Jagdish Nayak are the promoters of the company.

Share Holding Pre Issue83.63%
Share Holding Post-Issue61.56%

Clinitech IPO 2024 Restated Financial Information

Clinitech Laboratory Ltd’s revenue increased by 1.19% and its profit after tax dropped by -39.46% b/w March 31, 2024 and March 31, 2024.

Period Ended31 Mar 202431 Mar 202331 Mar 202231 Mar 2021
Assets560.79603.33368.74273.32
Revenue643.92636.34645.70459.63
Profit After Tax37.1261.3151.2640.24
Net Worth354.80238.08184.81139.03
Reserves and Surplus186.8088.0834.8172.37
Total Borrowing86.31102.9188.6153.67

Clinitech Laboratory Ltd. (CLL) operates diagnostic centers in Thane and Navi Mumbai, conducting over 3 lakh tests annually with a range of services. The company’s revenue is mainly from B2C, with B2B contributing 20.33% for FY24. It has 85 employees as of May 31, 2024.

CLL’s IPO offers 602,400 shares at Rs. 96 each to raise Rs. 5.78 crores, opening July 25 and closing July 29, 2024. Proceeds will fund diagnostic center expansion and general purposes. Post-IPO, the capital will rise to Rs. 2.28 crores, targeting a market cap of Rs. 21.91 crores. Financials show static revenue with fluctuating profits, and the issue is priced at a P/E of 58.90, considered high. The company has not declared dividends.

Visit Clinitech Laboratory Ltd. Official Website: Click here!

Leave a Comment